VRTX

Vertex Pharmaceuticals Incorporated

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$542.62

Price (1 Year)

$558.88 $423.92

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %3.9 / %30
Non-compliant assets / Total market cap %4.2 / %30
Non-compliant revenue / Total income %3.6 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain.

Website

Analysis (Turkish): VRTX Hissesi Caiz mi, Helal mi? Vertex Pharmaceuticals Incorporated Katılım Analizi